Optimal Contemporary Chronic Management of Hyperkalemia

Supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. This program is intended for healthcare providers.— cardio-met (@cardiomet_CE) June 15, 2021 3) Risk Factors for #hyperkalemia include: Advanced stages of #CKD, #heartfailure,...